IL17RB and cancer: A decrease of the CD44-positive population was also observed in IL-17RB-knockdown cells (Fig. 2B,C), and downregulation of cancer stemness activity of IL-17RB-knockdown cells was also shown by the sphere formation assay (Fig. 2D).